Iloprost
Showing 26 - 50 of 131
Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 6
Recruiting
- Hypertension, Pulmonary
- +2 more
- levosimendan at a dose of 6 mcg/kg
- milrinone at a dose of 50 mcg/kg
-
Athens, GreeceOnassis Cardiac Surgery Center
Feb 8, 2022
Pulmonary Hypertension, Pulmonary Arterial Hypertension Trial in Giessen, Bad Nauheim (Iloprost)
Completed
- Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Iloprost
-
Giessen, Hesse, Germany
- +1 more
Oct 25, 2018
Inhaled Treatment With Ventavis in Pulmonary Hypertension
Completed
- Hypertension, Pulmonary
- Iloprost (Ventavis, BAYQ6256)
-
Multiple Locations, Russian Federation(unnamed)
Mar 25, 2019
BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost
Completed
- Pulmonary Arterial Hypertension
- Iloprost
-
Bucheon, Korea, Republic of
- +5 more
Dec 25, 2018
Diabetes, Arteriosclerosis, Peripheral Arterial Occlusive Disease Trial in Vienna (Ilomedin)
Unknown status
- Diabetes
- +3 more
-
Vienna, AustriaDepartment of vascular and endovascular surgery, Georg Hagmüller
Oct 16, 2018
Chronic Thrombo-embolic Pulmonary Hypertension: Classification
Completed
- Chronic Thromboembolic Pulmonary Hypertension
- Idiopathic Pulmonary Arterial Hypertension
-
Sheffield, South Yorkshire, United KingdomSheffield Teaching Hospitals NHS Foundation Trust
Jun 23, 2022
Pulmonary Hypertension Trial in United States (Inhaled Iloprost (5 µg), Inhaled Placebo, Sildenafil)
Terminated
- Pulmonary Hypertension
- Inhaled Iloprost (5 μg)
- +3 more
-
Phoenix, Arizona
- +33 more
Mar 26, 2019
Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in Paris (BOTOX® solution, Placebo group)
Completed
- Raynaud Phenomenon Secondary to Systemic Sclerosis
- BOTOX® solution
- Placebo group
-
Paris, FranceHôpital Tenon
Feb 9, 2022
Systemic scleRosis and Progressive Digital ulcEr Disease.
Recruiting
- Scleroderma
- +4 more
-
Athens, GreeceLaikon Hospital of Athens
Mar 22, 2022
Lung Cancer Trial in Seoul (iloprost, normal saline)
Completed
- Lung Cancer
- iloprost
- normal saline
-
Seoul, Korea, Republic ofDepartment of Anaesthesiology and Pain Medicine, Anaesthesia and
Jun 19, 2018
Fibrotic Pulmonary Sequelae Post-COVID19 Infection Trial in Spain (Pirfenidone, Placebo)
Recruiting
- Fibrotic Pulmonary Sequelae Post-COVID19 Infection
- Pirfenidone
- Placebo
-
Hospitalet de Llobregat, Barcelona, Spain
- +7 more
Dec 29, 2021
Raynaud Phenomenon Trial in Grenoble (L-citrulline, Beetroot juice, L-citrulline )
Recruiting
- Raynaud Phenomenon
- L-citrulline
- +3 more
-
Grenoble, FranceGrenoble University Hospital
May 12, 2021
Pulmonary Arterial Hypertension With Inhaled Iloprost Using
Completed
- Pulmonary Hypertension
- Iloprost (Ventavis, BAYQ 6256)
-
Multiple Locations, Portugal(unnamed)
Apr 5, 2018
Pulmonary Arterial Hypertension Trial in Austria, Germany (lloprost(Ventavis,BAYQ6252, 20 µg/mL), lloprost(Ventavis,BAYQ6252, 10
Completed
- Pulmonary Arterial Hypertension
- lloprost(Ventavis,BAYQ6252, 20 µg/mL)
- lloprost(Ventavis,BAYQ6252, 10 µg/mL)
-
Graz, Steiermark, Austria
- +5 more
Sep 25, 2018
COMPERA / COMPERA-KIDS
Recruiting
- Pulmonary Arterial Hypertension (PAH)
- Pulmonary Hypertension (PH)
-
Leuven, Belgium
- +7 more
Jan 19, 2022
Pulmonary Arterial Hypertension Trial in Worldwide (PAH Therapies)
Recruiting
- Pulmonary Arterial Hypertension
- PAH Therapies
-
Los Angeles, California
- +97 more
Aug 16, 2022
Scleroderma, Systemic Trial in Grenoble (Iontophoresis of treprostinil, Iontophoresis of )
Completed
- Scleroderma, Systemic
- Iontophoresis of treprostinil
- Iontophoresis of placebo
-
Grenoble, FranceGrenoble Alps University Hospital
Apr 8, 2020
Systemic Sclerosis Trial in Sheffield (Exercise programme)
Recruiting
- Systemic Sclerosis
- Exercise programme
-
Sheffield, United KingdomSheffield Hallam University
Jul 19, 2022
Systemic Sclerosis, Digital Ulcer Trial in Milan (Autologous fat grafting, Sham procedure)
Unknown status
- Systemic Sclerosis
- Digital Ulcer
- Autologous fat grafting
- Sham procedure
-
Milan, ItalyUOC Day Hospital Reumatologia, ASST G. Pini-CTO
Jan 22, 2018
Hypertension, Pulmonary Trial in Japan (Iloprost (Ventavis inhaled, BAYQ6256))
Completed
- Hypertension, Pulmonary
- Iloprost (Ventavis inhaled, BAYQ6256)
-
Nagoya, Aichi, Japan
- +17 more
Dec 6, 2017
Efficacy of Ventavis Used in Real-life Setting.
Completed
- Pulmonary Arterial Hypertension
- Inhaled iloprost (Ventavis, BAYQ6256)
-
Many Locations, Poland(unnamed)
Oct 16, 2017
Raynaud's Phenomenon Isolated Primary, Raynaud's Phenomenon (Secondary), Healthy Trial in Grenoble (Biopsy)
Completed
- Raynaud's Phenomenon Isolated Primary
- +2 more
- Biopsy
-
Grenoble, Isère, FranceCHU of Grenoble Alpes
Apr 8, 2020
Via Insight Program in Class III Pulmonary Arterial Hypertension
Completed
- Pulmonary Arterial Hypertension
- Ventavis (Iloprost, BAYQ6256)
-
Multiple Locations, France(unnamed)
Dec 1, 2017
Prostacyclin Analogues in Pulmonary Arterial Hypertension
Completed
- Pulmonary Hypertension
-
Warsaw, PolandDepartment of Pulmonary Circulation, Thromboembolic Diseases and
Oct 8, 2020
Septic Shock Trial in Hillerød (Iloprost+eptifibatide, Placebo)
Completed
- Septic Shock
- Iloprost+eptifibatide
- Placebo
-
Hillerød, Capital Region, DenmarkDepartment of Anesthesia and Intensive Care, Nordsjællands Hospi
Apr 21, 2017